Codexis, Inc. (CDXS)
NASDAQ
Healthcare
Biotechnology
$1.48
▼ -25.63%
Market Cap
$134.5M
Sector
Healthcare
Industry
Biotechnology
Beta
2.50
52-Wk Range
0.96-3.87
CEO
Alison Moore
Country
US
Currency
USD
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engi…
Open full interactive analysis & DCF →